Clinical Trials
4 trialsNCT05033769 2023-04-18
AIRE
Institut fuer Frauengesundheit
Phase 4 Unknown
NCT02864030 2021-03-04
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4 Completed
NCT03583944 2019-11-27
A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer
Eisai Inc.
Phase 4 Completed
NCT01961544 2016-10-07
ESKIMO
Eisai Inc.
Phase 4 Completed